Compile Data Set for Download or QSAR
Report error Found 325 for UniProtKB: O00206
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633251(Preparation of 2-[(R)-3-decanoyloxytetradecanoylam...)
Affinity DataEC50:  13.7nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633252(US11458151, Compound 2 | Preparation of 2-[(R)-3-d...)
Affinity DataEC50:  64nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633253(US11458151, Compound 3 | Preparation of N [(R)-3-D...)
Affinity DataEC50:  3.95nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633254(Preparation of N [(R)-3-Decyloxytetradecanoyl]-O-[...)
Affinity DataEC50:  1.32nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633255(US11458151, Compound MPL | Monophosphoryl Lipid A ...)
Affinity DataEC50:  152nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633251(Preparation of 2-[(R)-3-decanoyloxytetradecanoylam...)
Affinity DataEC50:  19.7nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633252(US11458151, Compound 2 | Preparation of 2-[(R)-3-d...)
Affinity DataEC50:  41nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633254(Preparation of N [(R)-3-Decyloxytetradecanoyl]-O-[...)
Affinity DataEC50:  1.39nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633256(US11458151, Compound 5 | Preparation of N [(R)-3-D...)
Affinity DataEC50:  2.90nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633251(Preparation of 2-[(R)-3-decanoyloxytetradecanoylam...)
Affinity DataEC50:  10.2nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633254(Preparation of N [(R)-3-Decyloxytetradecanoyl]-O-[...)
Affinity DataEC50:  0.780nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633259(US11458151, Compound 8 | Preparation of 2-[(R)-3-(...)
Affinity DataEC50:  4.99nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM633260(US11458151, Compound 9 | Preparation of 2-[(R)-3-d...)
Affinity DataEC50:  15.7nMAssay Description:In vitro assays were conducted with Compounds 1-9 and the commercially available TLR4 agonist MPL. For measurement of biological activity various cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2023
Entry Details
US Patent

TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50239681(CHEMBL4074408)
Affinity DataEC50: >1.00E+5nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 cells assessed as induction of NF-kB activation-mediated SEAP production after 24 hrs by HTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250403(CHEMBL2386454)
Affinity DataEC50:  8.26E+3nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250404(CHEMBL4077391)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250405(CHEMBL4065144)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250406(CHEMBL4092815)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250407(CHEMBL4085061)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250408(CHEMBL4095263)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250409(CHEMBL4074812)
Affinity DataEC50:  7.42E+3nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250410(CHEMBL4089458)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250411(CHEMBL4061465)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250412(CHEMBL4091234)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250416(CHEMBL4063373)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250417(CHEMBL4101433)
Affinity DataEC50:  3.58E+3nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250418(CHEMBL4073017)
Affinity DataEC50:  3.75E+3nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250419(CHEMBL4064434)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250420(CHEMBL4085969)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250421(CHEMBL4097843)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250423(CHEMBL4105577)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250424(CHEMBL4087701)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250433(CHEMBL4095394)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250413(CHEMBL4078865)
Affinity DataEC50:  2.12E+3nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250434(CHEMBL4103142)
Affinity DataEC50:  920nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250415(CHEMBL4065290)
Affinity DataEC50:  3.27E+3nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250435(CHEMBL4100545)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250445(CHEMBL4103009)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250446(CHEMBL4061301)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250447(CHEMBL4077062)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250436(CHEMBL4083446)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250437(CHEMBL4093716)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250438(CHEMBL4079815)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250439(CHEMBL4068003)
Affinity DataEC50:  430nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50250414(CHEMBL4086723)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human TLR4 expressed in HEK293 blue cells assessed as induction of NF-kappaB activation-mediated SEAP production after 20 to 24 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50252943(CHEMBL4082672)
Affinity DataEC50:  1.17E+4nMAssay Description:Antagonist activity at TLR4 (unknown origin) expressed in human AD293 cells assessed as inhibition of LPS/ATP-stimulated TLR4/NF-kB signaling pathway...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50252944(CHEMBL2046559)
Affinity DataEC50:  3.95E+3nMAssay Description:Antagonist activity at TLR4 (unknown origin) expressed in human AD293 cells assessed as inhibition of LPS/ATP-stimulated TLR4/NF-kB signaling pathway...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50252945(CHEMBL4068115)
Affinity DataEC50:  3.27E+3nMAssay Description:Antagonist activity at TLR4 (unknown origin) expressed in human AD293 cells assessed as inhibition of LPS/ATP-stimulated TLR4/NF-kB signaling pathway...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50252955(CHEMBL4090046)
Affinity DataEC50:  6.35E+3nMAssay Description:Antagonist activity at TLR4 (unknown origin) expressed in human AD293 cells assessed as inhibition of LPS/ATP-stimulated TLR4/NF-kB signaling pathway...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2019
Entry Details Article
PubMed
TargetToll-like receptor 4(Human)
Inimmune

US Patent
LigandPNGBDBM50252957(CHEMBL4085674)
Affinity DataEC50:  1.40E+4nMAssay Description:Antagonist activity at TLR4 (unknown origin) expressed in human AD293 cells assessed as inhibition of LPS/ATP-stimulated TLR4/NF-kB signaling pathway...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2019
Entry Details Article
PubMed
Displayed 1 to 50 (of 325 total ) | Next | Last >>
Jump to: